Lifecome Biochemistry Co.,Ltd. (002868.SZ)

CNY 15.88

(-2.87%)

Operating Expenses Summary of Lifecome Biochemistry Co.,Ltd.

Lifecome Biochemistry Co.,Ltd.'s latest annual operating expenses in 2023 was 190.7 Million CNY , up 63.21% from previous year.
Lifecome Biochemistry Co.,Ltd.'s latest quarterly operating expenses in 2024 Q3 was 40.01 Million CNY , up 99.05% from previous quarter.
Lifecome Biochemistry Co.,Ltd. reported a annual operating expenses of 50.69 Million CNY in annual operating expenses 2022, down -15.93% from previous year.
Lifecome Biochemistry Co.,Ltd. reported a annual operating expenses of 60.3 Million CNY in annual operating expenses 2021, up 21.19% from previous year.
Lifecome Biochemistry Co.,Ltd. reported a quarterly operating expenses of 40.01 Million CNY for 2024 Q3, up 99.05% from previous quarter.
Lifecome Biochemistry Co.,Ltd. reported a quarterly operating expenses of 36.04 Million CNY for 2024 Q1, up 10.7% from previous quarter.

Annual Operating Expenses Chart of Lifecome Biochemistry Co.,Ltd. (2023 - 2012)

Historical Annual Operating Expenses of Lifecome Biochemistry Co.,Ltd. (2023 - 2012)

Year	Operating Expenses	Operating Expenses Growth
2023	190.7 Million CNY	63.21%
2022	50.69 Million CNY	-15.93%
2021	60.3 Million CNY	21.19%
2020	49.75 Million CNY	-3.18%
2019	51.39 Million CNY	9.26%
2018	47.03 Million CNY	0.88%
2017	46.62 Million CNY	-13.02%
2016	53.6 Million CNY	4.61%
2015	51.24 Million CNY	23.12%
2014	41.62 Million CNY	-5.6%
2013	44.09 Million CNY	11.86%
2012	39.42 Million CNY	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	30.11 Million CNY	-16.45%
2024 Q3	40.01 Million CNY	99.05%
2024 Q1	36.04 Million CNY	10.7%
2023 Q4	32.56 Million CNY	84.74%
2023 Q1	12.82 Million CNY	65.36%
2023 FY	82.73 Million CNY	63.21%
2023 Q2	19.72 Million CNY	53.72%
2023 Q3	17.62 Million CNY	-10.62%
2022 Q3	12.46 Million CNY	-31.37%
2022 Q2	18.16 Million CNY	47.73%
2022 Q4	7.75 Million CNY	-37.78%
2022 FY	50.69 Million CNY	-15.93%
2022 Q1	12.29 Million CNY	-30.77%
2021 Q2	14.62 Million CNY	13.34%
2021 Q3	15.01 Million CNY	2.69%
2021 Q4	17.76 Million CNY	18.3%
2021 FY	60.3 Million CNY	21.19%
2021 Q1	12.9 Million CNY	166.69%
2020 Q2	16.73 Million CNY	24.95%
2020 Q1	13.39 Million CNY	6.79%
2020 FY	49.75 Million CNY	-3.18%
2020 Q4	4.83 Million CNY	-67.31%
2020 Q3	14.79 Million CNY	-11.55%
2019 Q2	13.39 Million CNY	27.25%
2019 Q1	10.52 Million CNY	-32.41%
2019 FY	51.39 Million CNY	9.26%
2019 Q4	12.53 Million CNY	-15.99%
2019 Q3	14.92 Million CNY	11.39%
2018 Q4	15.57 Million CNY	46.75%
2018 FY	47.03 Million CNY	0.88%
2018 Q1	7.73 Million CNY	17.73%
2018 Q2	13.1 Million CNY	69.45%
2018 Q3	10.61 Million CNY	-19.0%
2017 Q1	11.58 Million CNY	-24.55%
2017 FY	46.62 Million CNY	-13.02%
2017 Q3	15.1 Million CNY	13.01%
2017 Q4	6.56 Million CNY	-56.51%
2017 Q2	13.36 Million CNY	15.39%
2016 Q4	15.35 Million CNY	50.24%
2016 Q3	10.21 Million CNY	-37.54%
2016 Q1	11.67 Million CNY	0.0%
2016 Q2	16.35 Million CNY	40.09%
2016 FY	53.6 Million CNY	4.61%
2015 FY	51.24 Million CNY	23.12%
2014 FY	41.62 Million CNY	-5.6%
2013 FY	44.09 Million CNY	11.86%
2012 FY	39.42 Million CNY	0.0%

Peer Operating Expenses Comparison of Lifecome Biochemistry Co.,Ltd.

Name	Operating Expenses	Operating Expenses Difference
Chengdu Kanghua Biological Products Co., Ltd.	898.63 Million CNY	78.778%
NanHua Bio-medicine Co., Ltd	137.65 Million CNY	-38.534%
Shandong Sito Bio-technology Co., Ltd.	235.57 Million CNY	19.047%
Porton Pharma Solutions Ltd.	1.16 Billion CNY	83.675%
Zhejiang Wecome Pharmaceutical Company Limited	262.87 Million CNY	27.453%
Guangdong VTR Bio-Tech Co., Ltd.	331.11 Million CNY	42.405%